Eugene Mannheimer
Stock Analyst at Freedom Capital Markets
(3.70)
# 2,084
Out of 5,044 analysts
72
Total ratings
50.5%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Eugene Mannheimer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Reiterated: Buy | $50 | $37.55 | +33.16% | 7 | Oct 1, 2026 | |
| NUTX Nutex Health | Reiterated: Buy | $56 → $306 | $206.29 | +48.33% | 2 | Sep 25, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $35 | $21.55 | +62.41% | 1 | Sep 14, 2026 | |
| DOCS Doximity | Downgraded: Hold | $31 → $27 | $30.50 | -11.48% | 2 | Sep 8, 2026 | |
| PHR Phreesia | Reiterated: Buy | $14 | $10.81 | +29.51% | 1 | Sep 3, 2026 | |
| TEM Tempus AI | Reiterated: Hold | $59 → $73 | $70.93 | +2.92% | 2 | Aug 31, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $44 | $49.74 | -11.54% | 1 | Aug 27, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $205 → $190 | $106.70 | +78.07% | 9 | Aug 20, 2026 | |
| CCSI Consensus Cloud Solutions | Reiterated: Buy | $38 → $44 | $36.71 | +19.86% | 2 | Aug 18, 2026 | |
| HNGE Hinge Health | Reiterated: Buy | $59 → $103 | $102.90 | +0.10% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $60 | $35.82 | +67.50% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $40 | $26.68 | +49.93% | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $3.76 | n/a | 7 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $0.0001 | n/a | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $12 | $2.00 | n/a | 6 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $42 | $0.0001 | n/a | 6 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.09 | n/a | 9 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $80 → $98 | $938.84 | n/a | 2 | May 1, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $9.15 | n/a | 1 | May 5, 2010 |
Astrana Health
Oct 1, 2026
Reiterated: Buy
Price Target: $50
Current: $37.55
Upside: +33.16%
Nutex Health
Sep 25, 2026
Reiterated: Buy
Price Target: $56 → $306
Current: $206.29
Upside: +48.33%
Omada Health
Sep 14, 2026
Reiterated: Buy
Price Target: $35
Current: $21.55
Upside: +62.41%
Doximity
Sep 8, 2026
Downgraded: Hold
Price Target: $31 → $27
Current: $30.50
Upside: -11.48%
Phreesia
Sep 3, 2026
Reiterated: Buy
Price Target: $14
Current: $10.81
Upside: +29.51%
Tempus AI
Aug 31, 2026
Reiterated: Hold
Price Target: $59 → $73
Current: $70.93
Upside: +2.92%
HeartFlow
Aug 27, 2026
Reiterated: Buy
Price Target: $44
Current: $49.74
Upside: -11.54%
iRhythm Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $205 → $190
Current: $106.70
Upside: +78.07%
Consensus Cloud Solutions
Aug 18, 2026
Reiterated: Buy
Price Target: $38 → $44
Current: $36.71
Upside: +19.86%
Hinge Health
Aug 10, 2026
Reiterated: Buy
Price Target: $59 → $103
Current: $102.90
Upside: +0.10%
Jul 31, 2026
Reiterated: Buy
Price Target: $52 → $60
Current: $35.82
Upside: +67.50%
Nov 20, 2025
Initiated Coverage: Hold
Price Target: $40
Current: $26.68
Upside: +49.93%
Jul 27, 2021
Reiterated: Buy
Price Target: $10 → $8
Current: $3.76
Upside: n/a
Jul 13, 2021
Reiterated: Buy
Price Target: $14 → $13
Current: $0.0001
Upside: n/a
Jun 22, 2021
Reiterated: Buy
Price Target: $13 → $12
Current: $2.00
Upside: n/a
May 7, 2021
Reiterated: Buy
Price Target: $46 → $42
Current: $0.0001
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $18
Current: $5.09
Upside: n/a
May 1, 2012
Downgraded: Hold
Price Target: $80 → $98
Current: $938.84
Upside: n/a
May 5, 2010
Reiterated: Buy
Price Target: $24
Current: $9.15
Upside: n/a